Email updates

Keep up to date with the latest news and content from BMC Veterinary Research and BioMed Central.

Open Access Research article

The ESR1 gene is associated with risk for canine mammary tumours

Kaja Sverdrup Borge1*, Malin Melin2, Patricio Rivera34, Stein Istre Thoresen5, Matthew Thomas Webster2, Henrik von Euler6, Kerstin Lindblad-Toh27 and Frode Lingaas1

Author Affiliations

1 Section of Genetics, Department of Basic Sciences and Aquatic Medicine, Norwegian School of Veterinary Science, P.O Box 8146 Dep., 0033 Oslo, Norway

2 Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden

3 During the present work: Department of Animal Breeding and Genetics, Uppsala University, Uppsala, Sweden

4 Currently: Bagarmossen Animal Hospital, Stockholm, Sweden

5 Section for Clinical Pathology, Department of Basic Sciences and Aquatic Medicine, Norwegian School of Veterinary Science, Oslo, Norway

6 Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden

7 Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, 02139, USA

For all author emails, please log on.

BMC Veterinary Research 2013, 9:69  doi:10.1186/1746-6148-9-69

Published: 10 April 2013



The limited within-breed genetic heterogeneity and an enrichment of disease-predisposing alleles have made the dog a very suitable model for the identification of genes associated with risk for specific diseases. Canine mammary cancer is an example of such a disease. However, the underlying inherited risk factors for canine mammary tumours (CMTs) are still largely unknown. In this study, 52 single nucleotide polymorphisms (SNPs) in ten human cancer-associated genes were genotyped in two different datasets in order to identify genes/alleles associated with the development of CMTs. The first dataset consisted of English Springer Spaniel (ESS) CMT cases and controls. ESS is a dog breed known to be at increased risk of developing CMTs. In the second dataset, dogs from breeds known to have a high frequency of CMTs were compared to dogs from breeds with a lower occurrence of these tumours.


We found significant associations to CMT for SNPs and haplotypes in the estrogen receptor 1 (ESR1) gene in the ESS material (best PBonf = 0.021). A large number of SNPs, among them several SNPs in ESR1, showed significantly different allele frequencies between the high and low risk breed groups (best PBonf = 8.8E-32, best PBPerm = 0.076).


The identification of CMT-associated SNPs in ESR1 in two independent datasets suggests that this gene might be involved in CMT development. These findings also support that CMT may serve as a good model for human breast cancer research.

Dog; Single nucleotide polymorphism; Allele frequency; Risk; Association; Mammary tumour; Estrogen receptor